Baolingbao Biology Co.,Ltd. (SHE:002286)

Baolingbao Biology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,966	2,729	3,011	3,380	5,028	4,210
Market Cap Growth	37.67%	-9.36%	-10.92%	-32.78%	19.45%	89.37%
Enterprise Value	3,898	2,816	3,117	3,446	4,715	3,911
Last Close Price	10.42	7.35	7.94	8.80	13.01	10.91
PE Ratio	26.68	24.55	55.79	25.38	24.94	84.42
Forward PE	-	46.25	46.25	46.25	46.25	46.25
PS Ratio	1.47	1.14	1.19	1.25	1.82	2.05
PB Ratio	1.80	1.34	1.52	1.69	2.77	2.63
P/TBV Ratio	1.90	1.42	1.62	1.80	2.99	2.87
P/FCF Ratio	38.74	46.42	23.15	-	44.33	15.79
P/OCF Ratio	12.82	10.97	10.67	109.66	24.38	10.57
EV/Sales Ratio	1.45	1.17	1.24	1.27	1.71	1.90
EV/EBITDA Ratio	13.33	10.75	17.55	13.36	14.83	25.79
EV/EBIT Ratio	22.57	19.60	52.14	22.01	22.14	70.64
EV/FCF Ratio	38.08	47.90	23.97	-	41.58	14.67
Debt / Equity Ratio	0.08	0.14	0.15	0.26	0.23	0.15
Debt / EBITDA Ratio	0.61	1.07	1.67	1.97	1.30	1.62
Debt / FCF Ratio	1.75	4.81	2.34	-	3.63	0.92
Asset Turnover	1.00	0.90	0.89	0.90	0.98	0.80
Inventory Turnover	9.00	7.49	7.58	7.75	9.56	9.29
Quick Ratio	1.12	0.88	0.87	0.83	0.89	0.81
Current Ratio	1.83	1.41	1.36	1.31	1.17	1.05
Return on Equity (ROE)	6.80%	5.52%	2.71%	6.98%	11.81%	3.15%
Return on Assets (ROA)	3.99%	3.37%	1.32%	3.24%	4.72%	1.35%
Return on Invested Capital (ROIC)	6.77%	5.92%	2.37%	7.24%	12.54%	3.07%
Return on Capital Employed (ROCE)	7.70%	6.80%	2.90%	7.00%	11.20%	3.30%
Earnings Yield	3.63%	4.07%	1.79%	3.94%	4.01%	1.19%
FCF Yield	2.58%	2.15%	4.32%	-6.62%	2.26%	6.33%
Dividend Yield	1.15%	1.29%	1.01%	0.91%	0.46%	0.55%
Payout Ratio	32.25%	49.76%	92.20%	39.43%	19.32%	48.76%
Buyback Yield / Dilution	-4.48%	-2.99%	2.74%	0.91%	-4.81%	-1.08%
Total Shareholder Return	-3.34%	-1.69%	3.74%	1.81%	-4.35%	-0.53%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.